Similar articles for PMID: 24259603

Year	Number of Results
1982	2
1983	2
1986	2
1987	3
1988	7
1989	3
1990	4
1991	2
1992	3
1993	5
1994	7
1995	8
1996	5
1997	7
1998	7
1999	7
2000	9
2001	8
2002	9
2003	13
2004	6
2005	8
2006	11
2007	7
2008	11
2009	6
2010	9
2011	14
2012	14
2013	20
2014	22
2015	37
2016	25
2017	29
2018	29
2019	22
2020	30
2021	23
2022	15
2023	11
2024	1

1

Ketamine continuous infusion for refractory status epilepticus in a patient with anticonvulsant hypersensitivity syndrome.

Esaian D, Joset D, Lazarovits C, Dugan PC, Fridman D. Esaian D, et al. Ann Pharmacother. 2013 Nov;47(11):1569-76. doi: 10.1177/1060028013505427. Epub 2013 Oct 9. Ann Pharmacother. 2013. PMID: 24259603

2

Ketamine successfully terminates malignant status epilepticus.

Prüss H, Holtkamp M. Prüss H, et al. Epilepsy Res. 2008 Dec;82(2-3):219-22. doi: 10.1016/j.eplepsyres.2008.08.005. Epub 2008 Sep 19. Epilepsy Res. 2008. PMID: 18804344

3

Ketamine use in the treatment of refractory status epilepticus.

Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. Synowiec AS, et al. Epilepsy Res. 2013 Jul;105(1-2):183-8. doi: 10.1016/j.eplepsyres.2013.01.007. Epub 2013 Jan 29. Epilepsy Res. 2013. PMID: 23369676

4

Terminating prolonged refractory status epilepticus using ketamine.

Hsieh CY, Sung PS, Tsai JJ, Huang CW. Hsieh CY, et al. Clin Neuropharmacol. 2010 May;33(3):165-7. doi: 10.1097/WNF.0b013e3181d1e3cd. Clin Neuropharmacol. 2010. PMID: 20098301

5

Early polytherapy for benzodiazepine-refractory status epilepticus.

Niquet J, Lumley L, Baldwin R, Rossetti F, Schultz M, de Araujo Furtado M, Suchomelova L, Naylor D, Franco-Estrada I, Wasterlain CG. Niquet J, et al. Epilepsy Behav. 2019 Dec;101(Pt B):106367. doi: 10.1016/j.yebeh.2019.06.011. Epub 2019 Oct 18. Epilepsy Behav. 2019. PMID: 31636007 Review.

6

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.

Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Claassen J, et al. Epilepsia. 2002 Feb;43(2):146-53. doi: 10.1046/j.1528-1157.2002.28501.x. Epilepsia. 2002. PMID: 11903460 Free article. Review.

7

Use of Ketamine in Barbiturate Coma for Status Epilepticus.

McGinn KA, Bishop L, Sarwal A. McGinn KA, et al. Clin Neuropharmacol. 2016 Jan-Feb;39(1):62-5. doi: 10.1097/WNF.0000000000000128. Clin Neuropharmacol. 2016. PMID: 26757317

8

Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital.

Tasker RC, Goodkin HP, Sánchez Fernández I, Chapman KE, Abend NS, Arya R, Brenton JN, Carpenter JL, Gaillard WD, Glauser TA, Goldstein J, Helseth AR, Jackson MC, Kapur K, Mikati MA, Peariso K, Wainwright MS, Wilfong AA, Williams K, Loddenkemper T; Pediatric Status Epilepticus Research Group. Tasker RC, et al. Pediatr Crit Care Med. 2016 Oct;17(10):968-975. doi: 10.1097/PCC.0000000000000900. Pediatr Crit Care Med. 2016. PMID: 27500721 Free PMC article.

9

Continuous Infusion Antiepileptic Medications for Refractory Status Epilepticus: A Review for Nurses.

Wiss AL, Samarin M, Marler J, Jones GM. Wiss AL, et al. Crit Care Nurs Q. 2017 Jan/Mar;40(1):67-85. doi: 10.1097/CNQ.0000000000000143. Crit Care Nurs Q. 2017. PMID: 27893511 Review.

10

Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome.

Koul R, Chacko A, Javed H, Al Riyami K. Koul R, et al. J Child Neurol. 2002 Dec;17(12):908-10. J Child Neurol. 2002. PMID: 12593465 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

427 results

Results by year